Sarı Kantaronun İnsan Sağlığına Etkisi ve Tıp Alanında Kullanım Potansiyeli
Referanslar
Yıldız H, Tüzün G, Erbayraktar E. Sarı Kantoron (Hypericum perforatum) Bitkisinin Antioksidan ve Antimikrobiyal Özellikleri Üzerine Bir Araştırma. ISPEC Journal of Science Instıtute. 2022;1(1):27-32.
Suryawanshi MV, Gujarathi PP, Mulla T, Bagban I. Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(6):3803-18. Epub 2024/01/04.
Nobakht SZ, Akaberi M, Mohammadpour AH, Tafazoli Moghadam A, Emami SA. Hypericum perforatum: Traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci. 2022;25(9):1045-58. Epub 2022/10/18.
Tokgöz HB, Altan F. Hypericum perforatum L.: a medicinal plant with potential as a curative agent against obesity-associated complications. Mol Biol Rep. 2020;47(11):8679-86. Epub 2020/10/23.
Zhang R, Ji Y, Zhang X, Kennelly EJ, Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol. 2020;254:112686. Epub 2020/02/27.
Clarke R. Are modern preparation methods compromising the efficacy of Chinese herbal medicines? An investigation using Guan Ye Lian Qiao (Hypericum perforatum L.). The Journal of Chinese Medicine. 2010(93):35.
Gunther R. Dioscorides,‘De materia medica,’The Greek herbal of Dioscordes. Hafner Publishing Co.: New York, NY, USA; 1968.
Solati K, Karimi M, Rafieian-Kopaei M, Abbasi N, Abbaszadeh S, Bahmani M. Phytotherapy for wound healing: The most important herbal plants in wound healing based on iranian ethnobotanical documents. Mini reviews in medicinal chemistry. 2021;21(4):500-19.
Ersoy E, EE Ö. Geçmişten Günümüze Hypericum perforatum (Sarı Kantaron) ve depresyon tedavisi-neler biliyoruz. J Lit Sci. 2020;9(2):137-48.
Mann JJ. The medical management of depression. N Engl J Med. 2005;353(17):1819-34. Epub 2005/10/28.
Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 1998;31 Suppl 1:16-21. Epub 1998/07/31.
Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;2008(4):CD000448. Epub 2008/10/10.
Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):118-27. Epub 2008/11/26.
Cui YH, Zheng Y. A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr Dis Treat. 2016;12:1715-23. Epub 2016/07/29.
Farasati Far B, Gouranmohit G, Naimi-Jamal MR, Neysani E, El-Nashar HAS, El-Shazly M, et al. The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectives. Phytotherapy research. 2024;38(7):3271-3295.
Farahani M, Shafiee A. Wound Healing: From Passive to Smart Dressings. Adv Health Mater. 2021;10(16):e2100477. Epub 2021/06/27.
Yu R, Zhang H, Guo B. Conductive Biomaterials as Bioactive Wound Dressing for Wound Healing and Skin Tissue Engineering. Nanomicro Lett. 2021;14(1):1. Epub 2021/12/04.
Derakhshanfar A, Moayedi J, Derakhshanfar G, Poostforoosh Fard A. The role of Iranian medicinal plants in experimental surgical skin wound healing: An integrative review. Iranian journal of basic medical sciences. 2019;22(6):590-600. Epub 2019/06/25.
Alanazi HH, Elfaki E. The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases. Frontiers in pharmacology. 2023;14:1084757. Epub 2023/03/14.
Sayar H, Gergerlioglu N, Seringec N, Ozturk P, Bulbuloglu E, Karabay G. Comparison of efficacy of topical phenytoin with hypericin in second-degree burn wound healing: an experimental study in rats. Medical science monitor basic research. 2014;20:36-46. Epub 2014/04/04.
Menegazzi M, Masiello P, Novelli M. Anti-Tumor Activity of Hypericum perforatum L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics. Antioxidants (Basel, Switzerland). 2020;10(1). Epub 2021/01/01.
Maduray K, Davids L. The anticancer activity of hypericin in photodynamic therapy. J Bioanal Biomed S. 2011;6(004).
Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P. The multifaceted photocytotoxic profile of hypericin. Molecular pharmaceutics. 2009;6(6):1775-89. Epub 2009/09/11.
Kleemann B, Loos B, Scriba TJ, Lang D, Davids LM. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death. Plos One. 2014;9(7):e103762. Epub 2014/07/31.
Liu YH, Liu GH, Mei JJ, Wang J. The preventive effects of hyperoside on lung cancer in vitro by inducing apoptosis and inhibiting proliferation through Caspase-3 and P53 signaling pathway. Biomedicine & pharmacotherapy. 2016;83:381-91. Epub 2016/10/25.
Reichling J, Weseler A, Saller R. A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry. 2001;34 Suppl 1:S116-8. Epub 2001/08/24.
Nazlı O, Baygar T, Demirci Dönmez Ç E, Dere Ö, Uysal A, Aksözek A, et al. Antimicrobial and antibiofilm activity of polyurethane/Hypericum perforatum extract (PHPE) composite. Bioorg Chem. 2019;82:224-8. Epub 2018/10/21.
Sytar O, Švedienė J, Ložienė K, Paškevičius A, Kosyan A, Taran N. Antifungal properties of hypericin, hypericin tetrasulphonic acid and fagopyrin on pathogenic fungi and spoilage yeasts. Pharmaceutical biology. 2016;54(12):3121-5. Epub 2016/08/27.
Montoya A, Daza A, Muñoz D, Ríos K, Taylor V, Cedeño D, et al. Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies. Antimicrobial agents and chemotherapy. 2015;59(9):5804-13. Epub 2015/07/15.
Chen H, Muhammad I, Zhang Y, Ren Y, Zhang R, Huang X, et al. Antiviral Activity Against Infectious Bronchitis Virus and Bioactive Components of Hypericum perforatum L. Frontiers in pharmacology. 2019;10:1272. Epub 2019/11/19.
Pu X-y, Liang J-p, Wang X-h, Xu T, Hua L-y, Shang R-f, et al. Anti-influenza A virus effect of Hypericum perforatum L. extract. Virologica sinica. 2009;24:19-27.
Wölfle U, Seelinger G, Schempp CM. Topical application of St. John's wort (Hypericum perforatum). Planta Med. 2014;80(2-3):109-20. Epub 2013/11/12.
Klemow KM, Bartlow A, Crawford J, Kocher N, Shah J, Ritsick M. Medical Attributes of St. John’s Wort (Hypericum perforatum). In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton FL: © 2011 by Taylor and Francis Group, LLC.; 2011.
Helgason CM, Frank JL, Johnson DR, Frank MG, Hendricks SE. The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology. 2000;46(3):247-51. Epub 2000/03/31.
Lee SH, Kwak CH, Lee SK, Ha SH, Park J, Chung TW, et al. Anti-Inflammatory Effect of Ascochlorin in LPS-Stimulated RAW 264.7 Macrophage Cells Is Accompanied With the Down-Regulation of iNOS, COX-2 and Proinflammatory Cytokines Through NF-κB, ERK1/2, and p38 Signaling Pathway. J Cell Biochem. 2016;117(4):978-87. Epub 2015/09/25.
Berköz M, Allahverdiyev O, Yıldırım M. Investigation of the effect of hyperforin and hypericin on inflammatory response in RAW 264.7 macrophages. Van Medical Journal. 2018; 25(2): 124-131.
Galeotti N, Vivoli E, Bilia AR, Vincieri FF, Ghelardini C. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity. Biochemical pharmacology. 2010;79(9):1327-36. Epub 2010/01/05.
Tian JY, Tao RY, Zhang XL, Liu Q, He YB, Su YL, et al. Effect of Hypericum perforatum L. extract on insulin resistance and lipid metabolic disorder in high-fat-diet induced obese mice. Phytotherapy research. 2015; 29(1):86-92. Epub 2014/10/01.
Ghosian Moghaddam MH, Roghani M, Maleki M. Effect of Hypericum perforatum Aqueous Extracts on Serum Lipids, Aminotransferases, and Lipid Peroxidation in Hyperlipidemic Rats. Research in cardiovascular medicine. 2016; 5(2):e31326. Epub 2016/03/08.
Suryawanshi MV, Gujarathi PP, Mulla T, Bagban I. Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(6):3803-18. Epub 2024/01/04.
Nobakht SZ, Akaberi M, Mohammadpour AH, Tafazoli Moghadam A, Emami SA. Hypericum perforatum: Traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci. 2022;25(9):1045-58. Epub 2022/10/18.
Tokgöz HB, Altan F. Hypericum perforatum L.: a medicinal plant with potential as a curative agent against obesity-associated complications. Mol Biol Rep. 2020;47(11):8679-86. Epub 2020/10/23.
Zhang R, Ji Y, Zhang X, Kennelly EJ, Long C. Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol. 2020;254:112686. Epub 2020/02/27.
Clarke R. Are modern preparation methods compromising the efficacy of Chinese herbal medicines? An investigation using Guan Ye Lian Qiao (Hypericum perforatum L.). The Journal of Chinese Medicine. 2010(93):35.
Gunther R. Dioscorides,‘De materia medica,’The Greek herbal of Dioscordes. Hafner Publishing Co.: New York, NY, USA; 1968.
Solati K, Karimi M, Rafieian-Kopaei M, Abbasi N, Abbaszadeh S, Bahmani M. Phytotherapy for wound healing: The most important herbal plants in wound healing based on iranian ethnobotanical documents. Mini reviews in medicinal chemistry. 2021;21(4):500-19.
Ersoy E, EE Ö. Geçmişten Günümüze Hypericum perforatum (Sarı Kantaron) ve depresyon tedavisi-neler biliyoruz. J Lit Sci. 2020;9(2):137-48.
Mann JJ. The medical management of depression. N Engl J Med. 2005;353(17):1819-34. Epub 2005/10/28.
Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. 1998;31 Suppl 1:16-21. Epub 1998/07/31.
Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;2008(4):CD000448. Epub 2008/10/10.
Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):118-27. Epub 2008/11/26.
Cui YH, Zheng Y. A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults. Neuropsychiatr Dis Treat. 2016;12:1715-23. Epub 2016/07/29.
Farasati Far B, Gouranmohit G, Naimi-Jamal MR, Neysani E, El-Nashar HAS, El-Shazly M, et al. The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectives. Phytotherapy research. 2024;38(7):3271-3295.
Farahani M, Shafiee A. Wound Healing: From Passive to Smart Dressings. Adv Health Mater. 2021;10(16):e2100477. Epub 2021/06/27.
Yu R, Zhang H, Guo B. Conductive Biomaterials as Bioactive Wound Dressing for Wound Healing and Skin Tissue Engineering. Nanomicro Lett. 2021;14(1):1. Epub 2021/12/04.
Derakhshanfar A, Moayedi J, Derakhshanfar G, Poostforoosh Fard A. The role of Iranian medicinal plants in experimental surgical skin wound healing: An integrative review. Iranian journal of basic medical sciences. 2019;22(6):590-600. Epub 2019/06/25.
Alanazi HH, Elfaki E. The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases. Frontiers in pharmacology. 2023;14:1084757. Epub 2023/03/14.
Sayar H, Gergerlioglu N, Seringec N, Ozturk P, Bulbuloglu E, Karabay G. Comparison of efficacy of topical phenytoin with hypericin in second-degree burn wound healing: an experimental study in rats. Medical science monitor basic research. 2014;20:36-46. Epub 2014/04/04.
Menegazzi M, Masiello P, Novelli M. Anti-Tumor Activity of Hypericum perforatum L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics. Antioxidants (Basel, Switzerland). 2020;10(1). Epub 2021/01/01.
Maduray K, Davids L. The anticancer activity of hypericin in photodynamic therapy. J Bioanal Biomed S. 2011;6(004).
Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P. The multifaceted photocytotoxic profile of hypericin. Molecular pharmaceutics. 2009;6(6):1775-89. Epub 2009/09/11.
Kleemann B, Loos B, Scriba TJ, Lang D, Davids LM. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death. Plos One. 2014;9(7):e103762. Epub 2014/07/31.
Liu YH, Liu GH, Mei JJ, Wang J. The preventive effects of hyperoside on lung cancer in vitro by inducing apoptosis and inhibiting proliferation through Caspase-3 and P53 signaling pathway. Biomedicine & pharmacotherapy. 2016;83:381-91. Epub 2016/10/25.
Reichling J, Weseler A, Saller R. A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry. 2001;34 Suppl 1:S116-8. Epub 2001/08/24.
Nazlı O, Baygar T, Demirci Dönmez Ç E, Dere Ö, Uysal A, Aksözek A, et al. Antimicrobial and antibiofilm activity of polyurethane/Hypericum perforatum extract (PHPE) composite. Bioorg Chem. 2019;82:224-8. Epub 2018/10/21.
Sytar O, Švedienė J, Ložienė K, Paškevičius A, Kosyan A, Taran N. Antifungal properties of hypericin, hypericin tetrasulphonic acid and fagopyrin on pathogenic fungi and spoilage yeasts. Pharmaceutical biology. 2016;54(12):3121-5. Epub 2016/08/27.
Montoya A, Daza A, Muñoz D, Ríos K, Taylor V, Cedeño D, et al. Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies. Antimicrobial agents and chemotherapy. 2015;59(9):5804-13. Epub 2015/07/15.
Chen H, Muhammad I, Zhang Y, Ren Y, Zhang R, Huang X, et al. Antiviral Activity Against Infectious Bronchitis Virus and Bioactive Components of Hypericum perforatum L. Frontiers in pharmacology. 2019;10:1272. Epub 2019/11/19.
Pu X-y, Liang J-p, Wang X-h, Xu T, Hua L-y, Shang R-f, et al. Anti-influenza A virus effect of Hypericum perforatum L. extract. Virologica sinica. 2009;24:19-27.
Wölfle U, Seelinger G, Schempp CM. Topical application of St. John's wort (Hypericum perforatum). Planta Med. 2014;80(2-3):109-20. Epub 2013/11/12.
Klemow KM, Bartlow A, Crawford J, Kocher N, Shah J, Ritsick M. Medical Attributes of St. John’s Wort (Hypericum perforatum). In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. Boca Raton FL: © 2011 by Taylor and Francis Group, LLC.; 2011.
Helgason CM, Frank JL, Johnson DR, Frank MG, Hendricks SE. The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro. Immunopharmacology. 2000;46(3):247-51. Epub 2000/03/31.
Lee SH, Kwak CH, Lee SK, Ha SH, Park J, Chung TW, et al. Anti-Inflammatory Effect of Ascochlorin in LPS-Stimulated RAW 264.7 Macrophage Cells Is Accompanied With the Down-Regulation of iNOS, COX-2 and Proinflammatory Cytokines Through NF-κB, ERK1/2, and p38 Signaling Pathway. J Cell Biochem. 2016;117(4):978-87. Epub 2015/09/25.
Berköz M, Allahverdiyev O, Yıldırım M. Investigation of the effect of hyperforin and hypericin on inflammatory response in RAW 264.7 macrophages. Van Medical Journal. 2018; 25(2): 124-131.
Galeotti N, Vivoli E, Bilia AR, Vincieri FF, Ghelardini C. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity. Biochemical pharmacology. 2010;79(9):1327-36. Epub 2010/01/05.
Tian JY, Tao RY, Zhang XL, Liu Q, He YB, Su YL, et al. Effect of Hypericum perforatum L. extract on insulin resistance and lipid metabolic disorder in high-fat-diet induced obese mice. Phytotherapy research. 2015; 29(1):86-92. Epub 2014/10/01.
Ghosian Moghaddam MH, Roghani M, Maleki M. Effect of Hypericum perforatum Aqueous Extracts on Serum Lipids, Aminotransferases, and Lipid Peroxidation in Hyperlipidemic Rats. Research in cardiovascular medicine. 2016; 5(2):e31326. Epub 2016/03/08.
Sayfalar
93-104
Gelecek
14 Ocak 2025
Telif Hakkı (c) 2025 Akademisyen Yayınevi Kitap DOI Portalı
